Literature DB >> 26721936

Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.

Konstantinos Karmiris1, Anastasios Avgerinos2, Aikaterini Tavernaraki1, Christos Zeglinas3, Pantelis Karatzas4, Theodoros Koukouratos4, Konstantinos A Oikonomou5, Athanasios Kostas6, Evanthia Zampeli7, Vasileios Papadopoulos8, Angeliki Theodoropoulou1, Nikos Viazis4, Dimitrios Polymeros8, Spyridon Michopoulos7, Giorgos Bamias6, Andreas Kapsoritakis5, Dimitrios G Karamanolis4, Gerassimos J Mantzaris4, Charalampos Tzathas3, Ioannis E Koutroubakis9.   

Abstract

BACKGROUND AND AIMS: Extraintestinal manifestations [EIMs] are common in inflammatory bowel disease [IBD]. Data on epidemiology and risk factors of EIMs in IBD patients are limited. The aim of this study was to investigate the prevalence of EIMs in a large cohort of Greek IBD patients and identify risk factors for their development.
METHODS: The study population consisted of IBD patients, who were followed in eight tertiary Greek hospitals. Demographic and clinical characteristics of patients were analysed. The diagnosis of EIMs was based on standard criteria and on specialist consultation.
RESULTS: In total, 1860 IBD patients (1001 with Crohn's disease [CD], 859 with ulcerative colitis [UC]) were registered. Among them 615 [33.1%] exhibited at least one EIM; 238 patients [38.6%] developed an EIM before IBD diagnosis. An association between active IBD and presence of an EIM was established in 61.1% of the patients. Arthritic [peripheral arthritis], mucocutaneous [erythema nodosum], and ocular [episcleritis] were the most common manifestations. EIMs were more prevalent in females, patients with CD, smokers [for all p <0.0001], patients with extensive UC [p = 0.007], and patients with a previous appendectomy [p < 0.0001] or a major IBD-related surgery [p = 0.012].
CONCLUSIONS: About one-third of Greek IBD patients developed at least one EIM. Of those, more than one-third had their EIM diagnosed before IBD, and in about two-thirds it was related to disease activity. EIMs were more frequently present in females and patients with extensive UC in multivariate analysis.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Extraintestinal manifestations; inflammatory bowel disease

Mesh:

Year:  2015        PMID: 26721936      PMCID: PMC4946768          DOI: 10.1093/ecco-jcc/jjv232

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  31 in total

Review 1.  Rare extraintestinal manifestations of inflammatory bowel disease.

Authors:  R M Hoffmann; W Kruis
Journal:  Inflamm Bowel Dis       Date:  2004-03       Impact factor: 5.325

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

Review 3.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

4.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Authors:  Maddalena Zippi; Claudia Corrado; Roberta Pica; Eleonora Veronica Avallone; Claudio Cassieri; Daniela De Nitto; Paolo Paoluzi; Piero Vernia
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

6.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 7.  Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

Review 8.  Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.

Authors:  E Gizard; A C Ford; J-P Bronowicki; L Peyrin-Biroulet
Journal:  Aliment Pharmacol Ther       Date:  2014-05-11       Impact factor: 8.171

9.  Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study.

Authors:  Taxiarchis Felekis; Konstantinos Katsanos; Margarita Kitsanou; Nikolaos Trakos; Vasileios Theopistos; Dimitrios Christodoulou; Ioannis Asproudis; Epameinondas V Tsianos
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

10.  Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.

Authors:  Timothy R Orchard; C N Chua; Tariq Ahmad; Hung Cheng; Kenneth I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  24 in total

Review 1.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 2.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

3.  Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease.

Authors:  Ying-Chao Li; Wei-Zhi Li; Chang-Rui Wu; Yun Feng; Li Ren; Chen Mi; Yang Li
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

4.  Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases.

Authors:  Marine Fauny; Nicolas Cohen; Caroline Morizot; Sophie Leclerc-Jacob; Daniel Wendling; Guillaume Lux; Valérie Laurent; Alain Blum; Patrick Netter; Cédric Baumann; Isabelle Chary-Valckenaere; Laurent Peyrin-Biroulet; Damien Loeuille
Journal:  Inflamm Intest Dis       Date:  2020-06-03

5.  Wasting condition as a marker for severe disease in pediatric Crohn's disease.

Authors:  Wook Jin; Dong-Hwa Yang; Hann Tchah; Kwang-An Kwon; Jung-Ho Kim; Su-Jin Jeong; Ki-Baik Hahm
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

6.  Ultrasonographic Assessment of Knee Cartilage Thickness in Patients with Ulcerative Colitis: Decreased Femoral Cartilage Thickness May Be an Indicator of Extraintestinal Manifestation in Patients with Mild Activity Ulcerative Colitis.

Authors:  Tolga Duzenli; Emre Ata; Murat Kosem
Journal:  Cartilage       Date:  2020-10-23       Impact factor: 3.117

Review 7.  Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Authors:  Kyla Pagani; Danitza Lukac; Aashni Bhukhan; Jean S McGee
Journal:  Am J Clin Dermatol       Date:  2022-04-20       Impact factor: 6.233

Review 8.  Ocular manifestations of rheumatic diseases.

Authors:  Adam Kemeny-Beke; Peter Szodoray
Journal:  Int Ophthalmol       Date:  2019-10-03       Impact factor: 2.031

9.  Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.

Authors:  Lucas Guillo; Ferdinando D'Amico; Mélanie Serrero; Karine Angioi; Damien Loeuille; Antonio Costanzo; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-08-10       Impact factor: 4.623

Review 10.  Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy.

Authors:  Alana Nevares; Robert Raut; Bonita Libman; Rula Hajj-Ali
Journal:  Curr Rheumatol Rep       Date:  2020-03-26       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.